recommendations strong buy investment alert emerging biotech company soon release ground breaking medical device vivo medical diagnostics inc stock symbol otc ivvo finalizing first ground breaking portable medical device prothrombin time monitor measures changes magnetic fields blood molecular level critical patients undergoing anticoagulation therapy heart attacks strokes measurement portable used real time achieve optimal medication levels essential successful treatment ivvo recently announced joint effort inverness medical innovations leading manufacturer marketer rapid diagnostic products order complete development prothrombin time monitor clinical trials prothrombin testing massive market continues grow projections excess 150 million 2005 500 million 2010 ivvo poised capitalize significant opportunity dont miss near term upside potential ivvo investment anaysis vivo medical diagnostics inc stock symbol otc ivvo short term target 3 00 12 month target 5 00 recommendations strong buy long term outlook excellent heart disease common cause death cardiovascular disease affects 60 million people worldwide largest area growth health care sector patient management growth caused patients chronic conditions forced make frequent costly hospital visits monitor condition vivo medical diagnostics utilizes hall effect well known physics phenomenon used measure changes magnetic fields molecular level ivvo taken proven science used imaging purposes applied many different applications including cardiovascular diabetes markets ivvo well established company operating eight years ivvo currently two additional products 2 nd clinical trials pregnancy labor monitor fetal heart rate monitor along 12 patents allow extend technology emerging medical solutions ivvo currently profitable additional royalty income beginning 2005 ivvo sufficient funds hand take well 2006 information within email contains forward looking statements within meaning section 27 securities act 1933 section 21 b securities exchange act 1934 statements express involve discussions respect predictions goals expectations beliefs plans projections objectives assumptions future events performance statements historical fact may forward looking statements please advised nothing within email shall constitute solicitation offer buy sell security mentioned herein newsletter neither registered investment advisor affiliated broker dealer newsletter affiliated vivo medical diagnostics inc way newsletter produced distributed independent third party statements made express opinion treated may buy sell securities mentioned time report includes forward looking statements within meaning private securities litigation reform act 1995 statements may include terms expect believe may move undervalued intend similar terms please due diligence investing profiled company may lose money investing penny stocks